Status:
COMPLETED
Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Arterial Obstructive Diseases
Coronary Disease
Eligibility:
All Genders
45+ years
Phase:
PHASE2
Brief Summary
The object of the study is to determine whether different doses of SCH 530348, when added to standard medical care in persons undergoing percutaneous coronary intervention, will increase the risk of b...
Eligibility Criteria
Inclusion
- A person who is 45 years or older and is mentally competent to provide a signed written informed consent.
- A person who is scheduled to undergo a percutaneous coronary intervention or a heart catheterization with the intent to undergo a percutaneous coronary intervention.
- If a woman is of childbearing potential (ie, before menopause), she must test negative for pregnancy and agree to use a reliable method of birth control.
Exclusion
- Pregnancy
- Recent stroke
- Active internal bleeding or a history of a bleeding disorder
- Increased risk of bleeding
- Severe high blood pressure
- Liver or kidney disease
- Low platelet count
- Condition such as alcoholism, mental illness, or drug dependence
- Ongoing chest pain
- Planned or ongoing treatment with a blood thinning medication
- A serious condition or illness that would interfere with participation in the study
Key Trial Info
Start Date :
August 30 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 28 2007
Estimated Enrollment :
1030 Patients enrolled
Trial Details
Trial ID
NCT00132912
Start Date
August 30 2005
End Date
January 28 2007
Last Update
May 25 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.